AI/ML Medical Device Regulation: PCCP, QMS, and FDA Guidance
Key Questions
What are PCCPs in the context of FDA AI/ML regulation?
Predetermined Change Control Plans allow manufacturers to outline anticipated AI/ML modifications in advance. They provide a structured pathway for SaMD updates under FDA guidance from August 2025.
How does QMSR affect AI/ML medical devices?
The Quality Management System Regulation from February 2026 updates requirements for design, manufacturing, and maintenance of AI devices. It aligns with GMLP principles for regulatory compliance.
Who benefits most from the PCCP framework?
Startups and established manufacturers gain clearer regulatory pathways for evolving AI/ML SaMD. Multiple guidance documents provide practical implementation details.
What triggers FDA oversight for AI medical devices?
Oversight applies when software meets the SaMD definition under section 201(h) of the Federal Food, Drug, and Cosmetic Act. Related articles cover definitions, GMLP, and quality management.
What resources cover FDA AI/ML guidance and QMS?
Key articles include a startup guide, PCCP-specific guidance, general FDA AI/ML rules updated in 2026, and a QMS design report for AI devices.
FDA's PCCP guidance (Aug 2025) and QMSR (Feb 2026) are reshaping AI/ML SaMD regulation. Multiple articles provide deep dives on regulatory pathways, GMLP, and quality management for AI/ML devices. The PCCP framework is particularly timely for startups and established manufacturers. Status: developing.